Indivior Pharmaceuticals Inc
INDV
Rankning i aktier
#3821
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Aktiekurs
$34.93
Senast synkroniserad: 2026-10-20
Marknadsvärde
$4.36B
Förändring (1 dag)
3.11%
Förändring (1 år)
44.98%
Land
US
Handel Indivior Pharmaceuticals Inc (INDV)
Kategori
Healthcare
P/B-tal för Indivior Pharmaceuticals Inc (INDV)
P/B-tal per October 2026 TTM: -20.59
Enligt Indivior Pharmaceuticals Inc senaste finansiella rapporter och aktiekurs är det aktuella P/B-talet (TTM) -20.59. I slutet av 2023 hade företaget ett P/B-tal på 31.28.
Historik för P/B-tal för Indivior Pharmaceuticals Inc från 2016 till 2026
P/B-tal vid årets slut
| År | P/B-tal | Ändra |
|---|---|---|
| 2026 (TTM) | -20.59 | 337.08% |
| 2024 | -4.71 | -115.07% |
| 2023 | 31.28 | -46.95% |
| 2022 | 58.97 | 375.46% |
| 2021 | 12.40 | -5.60% |
| 2020 | 13.14 | 623.09% |
| 2019 | 1.82 | -87.78% |
| 2018 | 14.87 | -176.13% |
| 2017 | -19.54 | 125.54% |
| 2016 | -8.66 | 0.00% |
P/B-tal för liknande företag eller konkurrenter
| Företag | P/B-tal | Skillnad i P/B-tal | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | -124.49% |
IN
|
